Literature DB >> 26954660

Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center.

Yen H Pham1, Brigid A Bingham1, Cynthia S Bell1, Susan A Greenfield1, Susan D John1, Lawrence H Robinson1, Mona A Eissa1.   

Abstract

OBJECTIVES: Pancreatic steatosis in adults has been proposed to be associated with obesity; however, data on pancreatic steatosis in children are lacking. Our study aimed to measure the prevalence of pancreatic steatosis in children and to examine its association with obesity and nonalcoholic fatty liver disease.
METHODS: This is a retrospective chart review study of 232 patients 2 to 18 years old who underwent abdominal computed tomographic imaging in the emergency department or inpatient ward within a 1-year time span and from whom demographics, anthropometrics, and medical history were obtained. Our radiologist determined mean Hounsfield unit (HU) measurements for the pancreas, liver, and spleen. A difference of -20 between the pancreas and spleen (psHU) and between the liver and spleen was used to determine fatty infiltration.
RESULTS: Of the 232 patients, 11.5% had a psHU less than -20. The prevalence of pancreatic steatosis was more than double among obese children (19%) than that in nonobese groups (8%). There is a significant correlation between the psHU and liver-spleen HU (r = 0.50, P < 0.001).
CONCLUSIONS: Pancreatic steatosis was identified in 10% of the study population and is associated with obesity. Also, pancreatic steatosis is significantly associated with nonalcoholic fatty liver disease. This is the first study assessing the prevalence of pancreatic steatosis in children.

Entities:  

Mesh:

Year:  2016        PMID: 26954660     DOI: 10.14423/SMJ.0000000000000432

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

Review 1.  The Clinical Implications of Fatty Pancreas: A Concise Review.

Authors:  Tawfik Khoury; Akwi W Asombang; Tyler M Berzin; Jonah Cohen; Douglas K Pleskow; Meir Mizrahi
Journal:  Dig Dis Sci       Date:  2017-08-08       Impact factor: 3.199

2.  Hypertension, but not body mass index, is predictive of increased pancreatic lipid content and islet dysfunction.

Authors:  Daniel M Tremmel; Austin K Feeney; Samantha A Mitchell; Peter J Chlebeck; Sierra A Raglin; Luis A Fernandez; Jon S Odorico; Sara D Sackett
Journal:  Am J Transplant       Date:  2019-12-16       Impact factor: 8.086

3.  Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.

Authors:  Melissa Martin; Biyao Zou; Joseph Hoang; Donghak Jeong; Rachel Bensen; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2020-08-14       Impact factor: 3.199

Review 4.  Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Authors:  T D Filippatos; K Alexakis; V Mavrikaki; D P Mikhailidis
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

Review 5.  Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.

Authors:  Roberto Catanzaro; Biagio Cuffari; Angelo Italia; Francesco Marotta
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

Review 6.  Impact of non-alcoholic fatty pancreas disease on glucose metabolism.

Authors:  Tse-Ya Yu; Chih-Yuan Wang
Journal:  J Diabetes Investig       Date:  2017-05-24       Impact factor: 4.232

7.  Relationship between fatty pancreas and hypertriglyceridemic waist phenotype: a cross-sectional study.

Authors:  Xiaoping Yu; Dan Wang; Weiming Xiao; Xinlin Shi; Qiang She; Hongguang Sun; Tingyue Qi; Renyan Xu; Guiqing Li; Xinnong Liu; Weijuan Gong; Zhigang Yan; Yanbing Ding; Guotao Lu
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 8.  Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer.

Authors:  Emily Truong; Stephen Pandol; Christie Jeon
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

Review 9.  Fatty Pancreas: Disease or Finding?

Authors:  Lucas de Lucena Simões E Silva; Matheus Santos de Sousa Fernandes; Eline Autran de Lima; José Tadeu Stefano; Claudia P Oliveira; José Jukemura
Journal:  Clinics (Sao Paulo)       Date:  2021-02-22       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.